Cencora, Inc. 8-K

What Happened

• Cencora, Inc. announced on March 23, 2026 (via a press release furnished in an 8‑K) that it entered into a definitive agreement on March 21, 2026 to acquire the retina business of EyeSouth Partners. The disclosure was made under Regulation FD and the press release is included as Exhibit 99.1 to the filing.
• The 8‑K does not include purchase price, closing date, or detailed financial terms.

Key Details

• Company: Cencora, Inc. (COR)
• Target: EyeSouth Partners’ retina business
• Agreement signed: March 21, 2026; press release filed: March 23, 2026 (Exhibit 99.1)
• Filing type: Form 8‑K, Item 7.01 (Regulation FD disclosure); no financial statements or material terms disclosed in this filing

Why It Matters

• The filing confirms Cencora is expanding through acquisition in the ophthalmology/retina space, which may affect future product, service or revenue mix for the company.
• Because the 8‑K omits deal economics and timing, investors should watch for future SEC filings or company releases that disclose purchase price, expected synergies, and closing conditions to assess the transaction’s financial impact.